MedPath

Aspartic acid

Generic Name
Aspartic acid
Brand Names
Aminosyn II 7 %, Sulfite-free, Aminosyn-PF 7%, Clinisol 15, Olimel, Periolimel, Plenamine, Premasol, Primene, Prosol, Trophamine 10 %
Drug Type
Small Molecule
Chemical Formula
C4H7NO4
CAS Number
56-84-8
Unique Ingredient Identifier
30KYC7MIAI
Background

One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.

Indication

There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.

Associated Therapies
Amino acid supplementation
Clinical Trials
Related News

A Study of an MMSET Inhibitor in Patients with Relapsed and Refractory Multiple Myeloma

Phase 1
Recruiting
Conditions
Myeloma
Multiple Myeloma
Myeloma Multiple
Interventions
Drug: Cohort A1 & A2
Drug: Cohort C1 & C2
First Posted Date
2022-12-15
Last Posted Date
2024-12-16
Lead Sponsor
K36 Therapeutics, Inc.
Target Recruit Count
125
Registration Number
NCT05651932
Locations
🇺🇸

Atrium Health, Levine Cancer Institute, Charlotte, North Carolina, United States

🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

🇫🇷

Universitaire de Lille, Villeneuve-d'Ascq, France

and more 16 locations

Vitamin d Level and it's Association With Disease Activity in Egyptian Rheumatoid Arthritis Patients

Conditions
Rheumatoid Arthritis (RA)
Interventions
First Posted Date
2022-08-03
Last Posted Date
2022-08-03
Lead Sponsor
Mariam Samir Farg
Target Recruit Count
130
Registration Number
NCT05486715

To Evaluate the Pharmacokinetic Drug Interactions, Safety and Drug Tolerance in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Treatment A
Drug: Treatment B
Drug: Treatment C
Drug: Treatment E
First Posted Date
2022-07-19
Last Posted Date
2022-07-19
Lead Sponsor
JW Pharmaceutical
Target Recruit Count
40
Registration Number
NCT05463497
Locations
🇰🇷

Jeonbuk National University Hospita, Jeonju, Jeollabuk-do, Korea, Republic of

The Study of Chinese Medicine for the Treatment of Primary Osteoporosis

Not Applicable
Conditions
Primary Osteoporosis
Interventions
Drug: Chinese medicine prescription
Drug: Placebo
First Posted Date
2022-05-12
Last Posted Date
2022-05-19
Lead Sponsor
Wangjing Hospital, China Academy of Chinese Medical Sciences
Target Recruit Count
120
Registration Number
NCT05370898
Locations
🇨🇳

Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing, China

High-Dose Vitamin D3 Supplementation in the Treatment of Human Immune Deficiency Virus Patients Trial

Phase 3
Completed
Conditions
Hypovitaminosis D
HIV-1-infection
Interventions
Other: placebo Oil
First Posted Date
2022-04-01
Last Posted Date
2022-04-11
Lead Sponsor
University of the Punjab
Target Recruit Count
95
Registration Number
NCT05306704
Locations
🇵🇰

Fatima Majeed, Lahore, Punjab/ lahore/Pakistan, Pakistan

🇵🇰

Govt Said Mitha Teaching Hospital Lahore, Lahore, Punjab/ lahore/Pakistan, Pakistan

A Study to Look at How Insulin NNC0471-0119 Works in the Body in People With Type 1 Diabetes When Injected by Insulin Pump

Phase 1
Completed
Conditions
Diabetes Mellitus, Type 1
Interventions
Drug: NNC0471-0119 A
Drug: NNC0471-0119 B
First Posted Date
2022-03-02
Last Posted Date
2023-10-12
Lead Sponsor
Novo Nordisk A/S
Target Recruit Count
19
Registration Number
NCT05262595
Locations
🇦🇹

Novo Nordisk Investigational Site, Graz, Austria

Outcome of High Dose Vitamin D on Prognosis of Sepsis Requiring Mechanical Ventilation

Phase 4
Completed
Conditions
Sepsis
Interventions
Drug: Vitamin D3 tablets
First Posted Date
2022-02-17
Last Posted Date
2022-11-07
Lead Sponsor
Ain Shams University
Target Recruit Count
80
Registration Number
NCT05244018
Locations
🇪🇬

Ain-Shams University Hospitals, Cairo, Egypt

Vitamin D Improves Clinical Manifestations in Asthmatic Children

Phase 1
Completed
Conditions
Asthma in Children
Interventions
First Posted Date
2021-12-22
Last Posted Date
2021-12-22
Lead Sponsor
Tanta University
Target Recruit Count
102
Registration Number
NCT05167617
Locations
🇪🇬

Tanta university, Tanta, Egypt

A Research Study Looking at New Protein-based Tablets in Healthy Male Participants

Phase 1
Completed
Conditions
Healthy Volunteers
High Blood Cholesterol Levels
Type 2 Diabetes
Interventions
Drug: NNC0385-0434 B
Drug: NNC0385-0434 C
Drug: NNC0385-0434 E
First Posted Date
2021-11-22
Last Posted Date
2024-05-29
Lead Sponsor
Novo Nordisk A/S
Target Recruit Count
384
Registration Number
NCT05129891
Locations
🇩🇪

Parexel International GmbH, Berlin, Germany

🇨🇦

Altasciences Company Inc., Montreal, Quebec, Canada

Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo

Not Applicable
Completed
Conditions
Autoimmune Disease Skin
Vitiligo, Generalized
Vitiligo
Autoimmune
Autoimmune Diseases
Interventions
Procedure: NB-UVB Phototherapy
Drug: Placebo
First Posted Date
2021-05-04
Last Posted Date
2023-02-14
Lead Sponsor
Hospital Universitario Dr. Jose E. Gonzalez
Target Recruit Count
26
Registration Number
NCT04872257
Locations
🇲🇽

Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Monterrey, Nuevo Leon, Mexico

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy